Peritoneal Dialysis Solution Biocompatibility Testing: A Realistic Alternative?

Duwe A.K. , Vas S.I. , Weatherhead J.W. Effects of the composition of peritoneal dialysis fluid on chemiluminescence, phagocytosis and bactericidal activity in vitro. Infect Immun 1981; 33: 130–5.

Ing B.L. , Gupta D.K. , Nawab Z.M. , Zhou F.Q. , Rahman M.A. , Daugirdas J.T. Suppression of neutrophil superoxide production by conventional peritoneal dialysis solution. Int J Artif Organs 1988; 11: 351–4.

Jörres A. , Jörres D. , Gahl G.M. , Kessel M. , Muller C. , Kottgen E. Leukotriene B4 and tumor necrosis factor release from leukocytes: Effect of peritoneal dialysate. Nephron 1991; 58: 276–82.

Liberek T. , Topley N. , Jorres A. , Coles G.A. , Gahl G.M. , Williams J.D. Peritoneal dialysis fluid inhibition of phagocyte function: Effects of osmolality and glucose concentration. J Am Soc Nephrol 1993; 3: 1508–15.

Liberek T. , Topley N. , Jorres A. , Petersen M. , Coles G.A. , Gahl G.M. Peritoneal dialysis fluid inhibition of polymorphonuclear leukocyte respiratory burst activation is related to the lowering of intracellular pH. Nephron 1993; 65: 260–5.

Topley N. , Alobaidi H.M. , Davies M. , Coles G.A. , Williams J.D. , Lloyd D. The effect of dialysate on peritoneal phagocyte oxidative metabolism. Kidney Int 1988; 34: 404–11.

van Bronswijk H. , Verbrugh H.A. , Bos H.J. , Heezius ECJM , Oe P.L. , van der Meulen J. Cytotoxic effects of commercial continuous ambulatory peritoneal dialysis (CAPD) fluids and of bacterial exoproducts on human mesothelial cells in vitro. Perit Dial Int 1989; 9: 197–202.

van Bronswijk H. , Verbrugh H.A. , Heezius E.C. , Verkooyen R.P. , van der Meulen J. , Verhoef J. Host defence in CAPD treatment: The effect of the dialysate on cell function. Contrib Nephrol 1990; 85: 67–72.

van Bronswijk H. , Verbrugh H.A. , Heezius H.C. , van der Meulen J. , Oe P.L. , Verhoef J. Dialysis fluids and local host resistance in patients on continuous ambulatory peritoneal dialysis. Eur J Clin Microbiol Infect Dis 1988; 7: 368–73.

Wieslander A. Cytotoxicity of glucose degradation products in PD-fluids. In: Nephrology. Lund: University of Lund; 1995.

Hjelle J.T. , Golinska B.T. , Waters D.C. , Steidley K.R. , McCarroll D.R. , Dobbie J.W. Isolation and propagation in vitro of peritoneal mesothelial cells. Perit Dial Int 1989; 9: 341–7.

Stylianou E. , Jenner L.A. , Davies M. , Coles G.A. , Williams J.D. Isolation, culture and characterization of human peritoneal mesothelial cells. Kidney Int 1990; 37: 1563–70.

Beavis M.J. , Topley N. Isolation, culture and characterisation of human peritoneal mesothelial cells. In: Doyle A. , Griffiths J.B. , Newell D.G. , eds. Cell and Tissue Culture: Laboratory Procedures. Specialised Vertebrate Cultures-Integumentary Systems and Muscular tissue. Chichester, UK: John Wiley; 1995.

Jorres A. , Ludat K. , Lang J. , Sander K. , Gahl G.M. , Frei U. Establishment and functional characterization of human peritoneal fibroblasts in culture: Regulation of interleukin-6 production by proinflammatory cytokines. J Am Soc Nephrol 1996; 7: 2192–201.

Topley N. In vitro biocompatibility of bicarbonate-based peritoneal dialysis solutions. Perit Dial Int 1997; 17: 42–7.

Topley N. , Kaur D. , Petersen M.M. , Jorres A. , Passlick-Deetjen J. , Coles G.A. Biocompatibility of bicarbonate buffered peritoneal dialysis fluids: Influence on mesothelial cell and neutrophil function. Kidney Int 1996; 49: 1447–56.

Betjes M.G.H. , Tuk C.W. , Struijk D.G. , Krediet R.T. , Arisz L. , Hart M. Interleukin-8 production by human peritoneal mesothelial cells in response to tumor necrosis factor a, interleukin-1, and medium conditioned by macrophages co-cultured with Staphylococcus epidermidis. J Infect Dis 1993; 168: 1202–10.

Topley N. , Brown Z. , Jorres A. , Westwick J. , Davies M. , Coles G.A. Human peritoneal mesothelial cells synthesize interleukin-8. Synergistic induction by interleukin-1 beta and tumor necrosis factor- alpha. Am J Pathol 1993; 142: 1876–86.

Topley N. , Floege J. , Wessel K. , Hass R. , Radeke H.H. , Kaever V. Prostaglandin E2 production is synergistically increased in cultured human glomerular mesangial cells by combinations of IL-1 and tumor necrosis factor-alpha 1. J Immunol 1989; 143: 1989–95.

Topley N. , Jorres A. , Luttmann W. , Petersen M.M. , Lang M.J. , Thierauch K.H. Human peritoneal mesothelial cells synthesize interleukin-6: Induction by IL-1 beta and TNF alpha. Kidney Int 1993; 43: 226–33.

Ha H. , Yu M.R. , Lee H.B. High glucose-induced PKC activation mediates TGF-beta 1 and fibronectin synthesis by peritoneal mesothelial cells. Kidney Int 2001; 59: 463–70.

Haslinger B. , Mandl-Weber S. , Sellmayer A. , Lederer S.R. , Sitter T. Effect of high glucose concentration on the synthesis of monocyte chemoattractant protein-1 in human peritoneal mesothelial cells: Involvement of protein kinase C. Nephron 2001; 87: 346–51.

Ito T. , Yorioka N. , Yamamoto M. , Kataoka K. , Yamakido M. Effect of glucose on intercellular junctions of cultured human peritoneal mesothelial cells. J Am Soc Nephrol 2000; 11: 1969–79.

Kumano K. , Schiller B. , Hjelle J.T. , Moran J. Effects of osmotic solutes on fibronectin mRNA expression in rat peritoneal mesothelial cells. Blood Purif 1996; 14: 165–9.

Sitter T. , Haslinger B. , Mandl S. , Fricke H. , Held E. , Sellmayer A. High glucose increases prostaglandin E2 synthesis in human peritoneal mesothelial cells: Role of hyperosmolarity. J Am Soc Nephrol 1998; 9: 2005–12.

Sitter T. , Mandl-Weber S. , Wornle M. , Haslinger B. , Goedde M. , Kooistra T. D-glucose increases the synthesis of tissuetype plasminogen activator (t-PA) in human peritoneal mesothelial cells. Thromb Haemost 1999; 82: 1171–6.

Witowski J. , Korybalska K. , Wisniewska J. , Breborowicz A. , Gahl G.M. , Frei U. Effect of glucose degradation products on human peritoneal mesothelial cell function. J Am Soc Nephrol 2000; 11: 729–39.

Witowski J. , Wisniewska J. , Korybalska K. , Bender T.O. , Breborowicz A. , Gahl G.M. Prolonged exposure to glucose degradation products impairs viability and function of human peritoneal mesothelial cells. J Am Soc Nephrol 2001; 12: 2434–41.

Wong T.Y. , Phillips A.O. , Witowski J. , Topley N. Glucose-mediated induction of TGF-beta1 and MCP-1 in mesothelial cells in vitro is osmolality and polyol pathway dependent. Kidney Int 2003; 63: 1404–16.

Topley N. What is the ideal technique for testing the biocompatibility of peritoneal dialysis solutions. Perit Dial Int 1995; 15: 205–9.

Ahmed M.I. , Rawal P.A. , Patel N.M. , Yu A.W. , Abraham M. , Harvey V.C. In vitro buffering capacity of residual peritoneal dialysis fluid: Implications for peritoneal dialysis therapy. Artif Organs 1992; 16: 416–18.

Jorres A. , Topley N. , Steenweg L. , Muller C. , Kottgen E. , Gahl G.M. Inhibition of cytokine synthesis by peritoneal dialysate persists throughout the CAPD cycle. Am J Nephrol 1992; 12: 80–5.

Witowski J. , Topley N. , Jorres A. , Liberek T. , Coles G.A. , Williams J.D. Effect of lactate-buffered peritoneal dialysis fluids on human peritoneal mesothelial cell interleukin-6 and prostaglandin synthesis. Kidney Int 1995; 47: 282–93.

Fusshoeller A. , Baehr J. , Grabensee B. , Plum J. Biocompatibility of a bicarbonate/lactate-buffered PD fluid tested with a double-chamber cell culture system. Perit Dial Int 2005; 25: 387–93.

Hurst S.M. , Wilkinson T.S. , McLoughlin R.M. , Jones S. , Horiuchi S. , Yamamoto N. IL-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation. Immunity 2001; 14: 705–14.

Breborowicz A. , Breborowicz M. , Pyda M. , Polubinska A. , Oreopoulos D. Limitations of CA125 as an index of peritoneal mesothelial cell mass. Nephron Clin Pract 2005; 100: c46–c51.

Ho-dac-Pannekeet M.M. , Hiralall J.K. , Struijk D.G. , Krediet R.T. Longitudinal follow-up of CA125 in peritoneal effluent. Kidney Int 1997; 51: 888–93.

Topley N. , Michael D. , Bowen T. CA125: Holy grail or a poisoned chalice. Nephron Clin Pract 2005; 100: c52–c54.

Visser C.E. , Brouwer-Steenbergen J.J. , Betjes M.G. , Koomen G.C. , Beelen R.H. , Krediet R.T. Cancer antigen 125: A bulk marker for the mesothelial mass in stable peritoneal dialysis patients. Nephrol Dial Transplant 1995; 10: 64–9.

Davies S.J. , Bryan J. , Phillips L. , Russell G.I. Longitudinal changes in peritoneal kinetics: The effects of peritoneal dialysis and peritonitis. Nephrol Dial Transplant 1996; 11: 498–506.

Davies S.J. , Phillips L. , Naish P.F. , Russell G.I. Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis. J Am Soc Nephrol 2001; 12: 1046–51.

Williams J.D. , Craig K.J. , Topley N. , Von Ruhland C. , Fallon M. , Newman G.R. Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol 2002; 13: 470–9.

Williams J.D. , Craig K.J. , Topley N. , Williams G.T. Peritoneal dialysis: Changes to the structure of the peritoneal membrane and potential for biocompatible solutions. Kidney Int Suppl 2003; 84: 158–61.

Williams J.D. , Craig K.J. , von Ruhland C. , Topley N. , Williams GT ; Biopsy Registry Study Group. The natural course of peritoneal membrane biology during peritoneal dialysis. Kidney Int Suppl 2003; 88: S43–9.

Jones S. , Holmes C.J. , Mackenzie R.K. , Stead R. , Coles G.A. , Williams J.D. Continuous dialysis with bicarbonate/lactate-buffered peritoneal dialysis fluids results in a long-term improvement in ex vivo peritoneal macrophage function. J Am Soc Nephrol 2002; 13(Suppl 1): S97–103.

MacKenzie R.K. , Holmes C.J. , Moseley A. , Jenkins J.P. , Williams J.D. , Coles G.A. Bicarbonate/lactate- and bicarbonate-buffered peritoneal dialysis fluids improve ex vivo peritoneal macrophage TNFalpha secretion. J Am Soc Nephrol 1998; 9: 1499–506.

Liberek T. , Lichodziejewska-Niemierko M. , Knopinska-Posluszny W. , Schaub T.P. , Kirchgessner J. , Passlick-Deetjen J. Generation of TNFalpha and interleukin-6 by peritoneal macrophages after overnight dwells with bicarbonate- or lactate-buffered dialysis fluid. Perit Dial Int 2002; 22: 663–9.